全文获取类型
收费全文 | 11326篇 |
免费 | 503篇 |
国内免费 | 165篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 177篇 |
妇产科学 | 78篇 |
基础医学 | 2720篇 |
口腔科学 | 195篇 |
临床医学 | 1250篇 |
内科学 | 1635篇 |
皮肤病学 | 174篇 |
神经病学 | 488篇 |
特种医学 | 160篇 |
外国民族医学 | 2篇 |
外科学 | 359篇 |
综合类 | 1753篇 |
预防医学 | 1345篇 |
眼科学 | 107篇 |
药学 | 929篇 |
5篇 | |
中国医学 | 257篇 |
肿瘤学 | 340篇 |
出版年
2024年 | 12篇 |
2023年 | 69篇 |
2022年 | 144篇 |
2021年 | 206篇 |
2020年 | 173篇 |
2019年 | 188篇 |
2018年 | 207篇 |
2017年 | 228篇 |
2016年 | 268篇 |
2015年 | 256篇 |
2014年 | 474篇 |
2013年 | 599篇 |
2012年 | 574篇 |
2011年 | 696篇 |
2010年 | 555篇 |
2009年 | 581篇 |
2008年 | 517篇 |
2007年 | 605篇 |
2006年 | 522篇 |
2005年 | 464篇 |
2004年 | 428篇 |
2003年 | 396篇 |
2002年 | 336篇 |
2001年 | 264篇 |
2000年 | 260篇 |
1999年 | 219篇 |
1998年 | 208篇 |
1997年 | 207篇 |
1996年 | 187篇 |
1995年 | 204篇 |
1994年 | 210篇 |
1993年 | 171篇 |
1992年 | 195篇 |
1991年 | 159篇 |
1990年 | 157篇 |
1989年 | 134篇 |
1988年 | 124篇 |
1987年 | 88篇 |
1986年 | 95篇 |
1985年 | 196篇 |
1984年 | 142篇 |
1983年 | 93篇 |
1982年 | 67篇 |
1981年 | 36篇 |
1980年 | 34篇 |
1979年 | 20篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Dorothee Bienzle Joyce Rousseau David Marom Jennifer MacNicol Linda Jacobson Stephanie Sparling Natalie Prystajecky Erin Fraser J. Scott Weese 《Emerging infectious diseases》2022,28(6):1154
We tested swab specimens from pets in households in Ontario, Canada, with human COVID-19 cases by quantitative PCR for SARS-CoV-2 and surveyed pet owners for risk factors associated with infection and seropositivity. We tested serum samples for spike protein IgG and IgM in household pets and also in animals from shelters and low-cost neuter clinics. Among household pets, 2% (1/49) of swab specimens from dogs and 7.7% (5/65) from cats were PCR positive, but 41% of dog serum samples and 52% of cat serum samples were positive for SARS-CoV-2 IgG or IgM. The likelihood of SARS-CoV-2 seropositivity in pet samples was higher for cats but not dogs that slept on owners’ beds and for dogs and cats that contracted a new illness. Seropositivity in neuter-clinic samples was 16% (35/221); in shelter samples, 9.3% (7/75). Our findings indicate a high likelihood for pets in households of humans with COVID-19 to seroconvert and become ill. 相似文献
62.
Violaine Planté-Bordeneuve Jared Gollob Sonalee Agarwal Marissa Betts Kyle Fahrbach 《Expert opinion on pharmacotherapy》2019,20(4):473-481
Background: Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a progressive, life-threatening disease. Until recently, tafamidis was the only approved pharmacotherapy. Patisiran significantly improved polyneuropathy and quality of life (QoL) in the phase III APOLLO trial. In the absence of direct comparisons, this analysis aimed to evaluate the comparative efficacy of tafamidis and patisiran in hATTR amyloidosis with polyneuropathy.Research design and methods: Randomized controlled trial evidence for tafamidis was identified by systematic literature review. Indirect treatment comparisons were performed using the standard pairwise Bucher method for endpoints used in both APOLLO and the tafamidis Fx-005 trial: change from baseline in Neuropathy Impairment Score-lower limbs (NIS-LL), Norfolk QoL-Diabetic Neuropathy questionnaire (QoL-DN), NIS-LL response, and mBMI vs. placebo. Inter-trial population differences were assessed by sensitivity analysis.Results: The base-case analysis (FAP Stage 1 APOLLO patients vs. intent-to-treat Fx-005 population) suggested patisiran had a greater treatment effect vs. tafamidis for all endpoints, with significant improvements in mean change in NIS-LL (–5.49) and QoL-DN (–13.10) from baseline to Month 18. Similar trends were observed in all sensitivity analyses.Conclusions: In the absence of direct comparisons, this analysis suggests patisiran has a greater treatment effect than tafamidis in patients with hATTR amyloidosis with polyneuropathy. 相似文献
63.
Dana Schneider Mariangela Vicarioto Serelina Coluzzi Antonella Matteocci Nicoletta Revelli Barbara Foglieni Patrizia Artusi Donatella Londero Anna Quaglietta Giancarla Barrotta Domenico Visceglie Giuseppina Portararo Jonella Gilsdorf 《Trasfusione del sangue》2022,20(4):329
BackgroundABO antibody titres are important in many clinical decisions; however, much variability is observed in titre results. For reliable and reproducible titre results, automated ABO titration methods have been developed. In this 10-site study, we evaluated the equivalency of the automated ABO titration assays on the Galileo NEO, a fully automated blood bank analyzer (Immucor, Inc.) to manual titration with gel Column Agglutination Technology (CAT), as well as the reproducibility of both methods.Materials and methodsTen different locations participated in this study. The equivalency study included 70 random samples at each site. The reproducibility study tested the same blinded 30-sample panel at each study site. Anti-A and anti-B IgM and IgG antibody titres were tested with both the automated and manual methods; additionally, dithiothreitol (DTT) treatment was used to inactivate IgM antibodies in the manual CAT method.ResultsThe equivalency between CAT manual method and Galileo NEO automated titres at each site ranged from 38 to 88%; equivalency for each isotype was 66.2% for IgM, 60.6% for IgG, and 88.5% for DTT-treated IgG. The reproducibility study evaluated the titre variation of each sample obtained from the 10 sites. The average titre ranges (in doubling dilutions) for the automated and manual methods, respectively, were 2.15±1.0 and 4.03±1.8 for IgM, and 1.53±0.7 and 4.10±1.9 for IgG; for the manual DTT-treated IgG, the average titre range was 3.45±1.8 doubling dilutions.DiscussionThe results demonstrated that the Galileo NEO automated and manual CAT ABO titres are not equivalent. However, the study also demonstrated that titre reproducibility is enhanced with the Galileo NEO automated ABO titration assays relative to the manual CAT ABO titration method. Therefore, to improve management of patients receiving care across multiple institutions, our study supports the use of automated ABO titration. 相似文献
64.
Zheng Chen Xifeng Hu Xiangdong Wu Yu Li Zhen Ding Qinghua Zeng Tong Wan Jingyi Yin Huansheng Wu 《Viruses》2022,14(7)
Porcine circovirus-like virus (PCLV) is a member of circovirus that contains a single-strand DNA genome, which may be one of the pathogens that causes diarrheal symptoms in pigs. The Rep protein encoded by the genome of PCLV may be responsible for viral genome replication. The development of serological detection methods for PCLV is of great necessity for clinical diagnosis, as well as epidemiological investigations. Therefore, this study attempted to build an indirect enzyme-linked immunosorbent assay (ELISA) to examine antibodies against PCLV based on the His-tagged recombinant Rep protein. Full-length PCLV Rep protein was induced and expressed in E. coli and was purified as an antigen to establish an ELISA detection kit. The purified Rep protein was used to inject into mice to produce specific antibodies. There was no cross-reaction of Rep-based ELISA with antisera against other porcine viruses. The intra-assay and inter-assay coefficient variations (CVs) were 0.644–8.211% and 0.859–7.246%, respectively, indicating good repeatability. The non-cross-reaction with TGEV, PRRSV and PCV2 testing showed high sensitivity and high specificity for this ELISA assay. A total of 1593 serum samples collected from different pig farms in Jiangxi Province were tested for anti-PCLV Rep antibodies, and 284 (17.83%) of the 1593 samples were Rep antibody positive. Altogether, the indirect ELISA detection tool developed in this study could be applied to examine serum of PCLV antibodies with good repeatability, high sensitivity and high specificity. In addition, field sample detection results suggested that the PCLV antibody has a low prevalence in pig populations in Jiangxi Province of China. 相似文献
65.
66.
Paola Iaccarino Idelson Enza Speranza Maurizio Marra Fabrizio Pasanisi Rosa Sammarco Ferruccio Galletti Pasquale Strazzullo Antonio Barbato 《Nutrients》2022,14(15)
(1) Background: Gaucher disease (GD) is a rare lysosomal storage disease. The few studies analyzing Resting Energy Expenditure (REE) in GD involved mainly untreated patients and supported a hypermetabolic condition possibly due to the associated inflammatory state. Definitive conclusions could not be drawn also because of the heterogeneity and the small size of the samples investigated. In order to expand current knowledge concerning, in particular the condition of patients under Enzyme Replacement Therapy (ERT), we evaluated the nutritional status of a relatively large sample of GD patients followed at Federico II University Hospital in Naples, Italy. (2) Methods: The study, having a cross-sectional design and involving 26 patients on ERT, included routine biochemical analyses, bioelectrical impedance analysis, indirect calorimetry, and administration of food frequency and physical activity questionnaires. The results in GD patients were compared with those from an appropriate control group. (3) Results: GD patients had normal biochemical parameters in 80% of cases, except for HDL-cholesterol, consumed a hyper-lipidic diet, and had a 60% prevalence of overweight/obesity. Body composition did not differ between patients and controls; however, measured REE was significantly lower than predicted and was reduced in comparison with the healthy controls. (4) Conclusions: This study provided novel elements to the present knowledge about REE and the nutritional status of GD patients under ERT. Its results warrant confirmation in even larger GD population samples and a more in-depth investigation of the long-term effects of treatment superimposed on the basic pathophysiological disease condition. 相似文献
67.
68.
安肠胶囊对慢性溃疡性结肠炎患者黏膜局部免疫细胞的影响 总被引:3,自引:0,他引:3
目的 探讨安肠胶囊对慢性溃疡性结肠炎 (ulcerativecolitis,UC)黏膜局部免疫细胞的影响。方法 应用兔抗人IgA、兔抗人IgG、兔抗人IgM多克隆抗体及鼠抗人肥大细胞类胰蛋白酶单克隆抗体 ,通过免疫组化技术 ,对 13例UC患者结直肠黏膜标本及 10例正常黏膜进行Ig细胞和肥大细胞密度检测。结果 UC患者黏膜固有层的IgA细胞数量低于正常黏膜 ,IgG细胞和肥大细胞密度均高于正常黏膜 ,经安肠胶囊治疗后 ,IgA细胞的数量较治疗前有所增加(P <0 .0 0 1) ,IgG和肥大细胞下降 (P <0 .0 5 ) ;治疗后IgA细胞、IgG细胞和肥大细胞与正常黏膜相比无显著性差异 (P >0 .0 5 ) ;治疗前后的IgM细胞数量和正常黏膜相比无显著性差异。结论 结直肠黏膜局部体液免疫细胞 (浆细胞 )亚群的活化与溃疡性结肠炎的活动密切相关 ,安肠胶囊通过对局部IgA ,IgG细胞和肥大细胞数量的调节而达到治疗目的 相似文献
69.
Yuqin Zhang Wei Xu Huang Li Xun Zhang Yufa Xia Kedan Chu Lidian Chen 《Journal of ethnopharmacology》2013
Ethnopharmacological relevance
Tripterygium wilfordii Hook f. is one of Traditional Chinese Medicines which is commonly used to treat rheumatoid arthritis (RA). The total alkaloids were the main constituent part of Tripterygium wilfordii Hook f. It has a great significance to study the effects of the total alkaloids of Tripterygium wilfordii Hook f. (ATW) on RA.Aim of the study
This paper aims at investigating the therapeutic effect of ATW on RA and its possible mechanism, and providing a theoretical and experimental basis for the clinical use of ATW.Materials and methods
The model of wistar rats of type II collagen-induced arthritis (CIA) was made, and the rats were perfused a stomach with ATW for 4 weeks continuously. Then the levels of interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-<alpha>, in the serum of CIA rats were detected by enzyme linked immunosorbent assay (ELISA), and the joint pathological section of CIA rats was observed by hematoxylin and eosin (HE) staining method and the expression of IL-6, IL-8, nuclear factor kappa B (NF-κB), TNF-α were measure by immunohistochemistry staining method.Results
Compared with model group, ATW could significantly reduce paw swelling and suppresse articular cartilage degenerated. The results also found that there was significant reduction levels of IL-6, IL-8 and TNF-α in serum of CIA rats treated with ATW and ATW inhibited the expression of IL-6, IL-8, NF-κB, TNF-α in synovial tissue.Conclusion
ATW not only could inhibit the symptom of CIA rats significantly but also could inhibit the production of IL-6, IL-8, TNF-α in serum and the expression of IL-6, IL-8, NF-κB and TNF-α in synovial tissue targeting the inflammatory. ATW would be a drug as a novel botanical drug for the treatment of RA. 相似文献70.